Companies Dominating the Whole Exome Sequencing Landscape
- Illumina, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories Inc.
- Ambry Genetics
- Eurofins Discovery
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies Inc.
- BGI Group
- Macrogen Inc.
- Azenta US Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Whole Exome Sequencing Market in 2025 is evaluated at USD 5.55 billion.
The global market size crossed USD 4.62 billion in 2024 and is likely to register a CAGR of over 25.1%, exceeding USD 84.92 billion revenue by 2037.
North America is estimated to witness highest growth rate by 2037, driven by prevalence of chronic diseases and demand for precision medicine.
The major players in the market include Illumina, Inc., Bio-Rad Laboratories Inc., Ambry Genetics, Eurofins Discovery, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., BGI Group, Macrogen Inc., Azenta US Inc.
